Skip to content

Cocrystal Pharma, Inc.

COCP· NasdaqCore metricsCIK 1412486

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · -3.33%
Market cap
$19.55M
19.26M shares
Filings
674
$105.00K
Q2 2026−69.3% FY20 yoy
-$3.16M
Q2 2026N/M FY25 yoy
-$3.18M
Q2 2026N/M FY25 yoy
-$8.20M
FY 2025derivedN/M FY25 yoy
-$0.23
Q2 2026N/M FY25 yoy
$7.03M
FY 2025−28.8% FY25 yoy
$19.55M
—
—
18.7×
-41.96%
—

FY2025 figures · derived

Price

$1.0210.18%$0.11past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$2.01MFY 2020
$12.71M0FY 2011FY 2019FY 2020
PeriodEndedValueKindSource trail
FY 20202020-12-31$2,014,000reported
FY 20192019-12-31$6,564,000reported
FY 20112011-12-31$12,712,091reported

Pharmaceutical preparations

Cocrystal Pharma, Inc. is the 388th largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Cocrystal Pharma, Inc. · CIK 1412486 · Engraved from SEC EDGAR